Setrics Tracker

Pages

Anti-Smoking Drug Linked to Heart Risks

By at August 8, 2011 | 3:09 pm | Print

A study found that Pfizer’s anti-smoking drug Chantix poses significant cardiovascular risks, a claim the pharmaceutical giant immediately denied while defending the drug’s benefits. The study, published in the Canadian Medical Association Journal, showed Chantix is linked to a 72 percent greater risk of hospitalization due to a serious adverse cardiovascular event like a heart attack or arrhythmia.

“We have known for many years that Chantix is one of the most harmful prescription drugs on the US market.  It causes loss of consciousness, visual disturbances, suicides, violence, depression and worsening of diabetes…and now add CV risks.” study investigator.

Misc Articles

Related Posts

Trackbacks For This Post

  1. […] Cigarette smoking has long been debated by the common folk as a good thing by some and a bad thing by others. Fortunately, today we have an endless amount of science and evidenced based facts that prove the dangers, cost, and downfalls of cigarette smoking. My goal in this article is to introduce you to the immediate dangers of smoking, long term effects of smoking, how to quit if you choose, and how to prevent others from ever picking up this awful costly habit. […]

One Comment


Post Your Comments